Status:
COMPLETED
PANS - A Detailed Study of the Patients, Their Symptoms, Biomarkers and Treatment Offered in a Scandinavian Cohort
Lead Sponsor:
Karolinska Institutet
Collaborating Sponsors:
The Swedish Research Council
Conditions:
Obsessive-compulsive Disorder With Acute Onset
PANDAS
Eligibility:
All Genders
Brief Summary
Background: Obsessive-compulsive disorder (OCD) is considered one of the most debilitating of the psychiatric illnesses, yet much remains unclear regarding causes and cures. A diagnostic subgroup with...
Detailed Description
Data collected comprises: Retrospective data * Interview * Medical records * Five to Fifteen (FTF) * Cunningham panel of PANS biomarkers result prior to inclusion (at time point 1) * Change in Clini...
Eligibility Criteria
Inclusion
- Inclusion Criteria the PANS-group:
- Scandinavian patients assessed with the Cunningham panel through Wieslab, Lund, Sweden or Statens Serum Institut (SSI), Copenhagen, Denmark.
- Exclusion Criteria PANS-group:
- intellectual disability, non-Swedish speaking
- Inclusion Criteria Psychiatric Controls:
- diagnosed with a psychiatric disorder
- age \<40 years
- Exclusion Criteria Psychiatric Controls:
- intellectual disability, non-Swedish speaking
- Inclusion Criteria Healthy Controls:
- age and sex matched to the PANS-group
- Exclusion Criteria Healthy controls:
- intellectual disability, non-Swedish speaking
Exclusion
Key Trial Info
Start Date :
June 1 2014
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
185 Patients enrolled
Trial Details
Trial ID
NCT02190292
Start Date
June 1 2014
Last Update
October 22 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Northern Stockholm psychiatry
Stockholm, Sverige, Sweden, SE-112 81